Abstract
Adriamycin (ADM) entrapped in liposomes (Lip-ADM) was prepared and its therapeutic effects studied using the mouse leukemia cell line, P388, which metastasized to axillary lymph nodes after inoculation into the foot pads of CDF1 mice. Lip-ADM injections (7.5 mg/kg) were given into the foot pad at two-day intervals. Two series of experiments were performed; one in which Lip-ADM was administered on days 1, 3 and 5 following tumor inoculation, and the other in which it was administered on days 5 and 7. Both Lip-ADM injection regimens significantly inhibited metastases to the lymph nodes as compared with mice given injections of saline solution. Furthermore, the therapeutic effects of three Lip-ADM injections were significantly greater than the effects of free ADM. Histological examinations of lymph nodes revealed that three injections of Lip-ADM completely eliminated tumor cells, whereas viable tumor cells were still observed in the lymph nodes after treatment with free ADM. The results of this study suggest that Lip-ADM is useful for the treatment of lymph nodes metastases and that the local injection of Lip-ADM, through such means as endoscopy, would be recommended as a clinical mode of application.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gregoriadis G. The liposome drug-carrier concept: its development and future. In: Gregoriadis G and Allison AC eds., Liposomes in biological system, New York: John Wiley and Sons, Ltd. 1980; 25–86.
Weinstein JN. Liposomes as drug carriers in cancer therapy. Cancer Treat Rep 1984; 68: 127–135.
Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z. Liposomes asin vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res 1982; 42: 4734–4739.
Forssen EA, Tokes ZA. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. Proc Natl Acad Sci USA 1981; 78: 1873–1877.
Ryman BE, Barrett GM, Begent RHJ. Possible localization of tumours and metastases by liposomes. Biol Cell 1983; 47: 71–81.
Mayhew E, Rustum YM, Szoka F, Papahadjopoulos D. Role of cholesterol in enhancing the anti-tumor activity of 1-B-D-arabinofuranosylcytosine entrapped in reverse phase evaporation vesicles. Cancer Treat Rep 1979; 63: 1923–1928.
Tyrrell DA, Heath TD, Colley CM, Ryman BE. New aspects of liposomes. Biochem Biophys Acta 1976; 457: 259–302.
Konno H, Suzuki H Tadakuma T, Kumai K, Yasuda T, Kubota T, Ohta S, Nagaike K, Hosokawa S, Ishibiki K, Abe O, Saito K. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human fetoprotein monoclonal antibody. Cancer Res 1987; 47: 4471–4477.
Kao YJ, Juliano RL. Interaction of liposomes with reticuloendothelial system: effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. Biochim Biophys Acta 1981; 677: 453–461.
Hashimoto Y, Sugawara M, Masuko T, Hojo H. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Cancer Res 1983; 43: 5328–5334.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Konno, H., Tadakuma, T., Kumai, K. et al. The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases. The Japanese Journal of Surgery 20, 424–428 (1990). https://doi.org/10.1007/BF02470826
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470826